Classification of Alzheimer’s Disease Based on Deep Learning of Brain Structural and Metabolic Data

Abstract

To improve the diagnosis and classification of Alzheimer’s disease (AD), a modeling method is proposed based on the combining magnetic resonance images (MRI) brain structural data with metabolite levels of the frontal and parietal regions. First, multi-atlas brain segmentation technology based on T1-weighted images and edited magnetic resonance spectroscopy (MRS) were used to extract data of 279 brain regions and levels of 12 metabolites from regions of interest (ROIs) in the frontal and parietal regions. The t-test combined with false discovery rate (FDR) correction was used to reduce the dimensionality in the data, and MRI structural data of 54 brain regions and levels of 4 metabolites that obviously correlated with AD were screened out. Lastly, the stacked auto-encoder neural network (SAE) was used to classify AD and healthy controls (HCs), which judged the effect of classification method by fivefold cross validation. The results indicated that the mean accuracy of the five experimental model increased from 96 to 100%, the AUC value increased from 0.97 to 1, specificity increased from 90 to 100%, and F1 value increased from 0.97 to 1. Comparing the effect of each metabolite on model performance revealed that the gamma-aminobutyric acid (GABA) + levels in the parietal region resulted in the most significant improvement in model performance, with the accuracy rate increasing from 96 to 98%, the AUC value increased from 0.97 to 0.99 and the specificity increasing from 90 to 95%. Moreover, the GABA + levels in the parietal region was significantly correlated with Mini Mental State Examination (MMSE) scores of patients with AD (r = 0.627), and the F statistics were largest (F = 25.538), which supports the hypothesis that dysfunctional GABAergic system play an important role in the pathogenesis of AD. Overall, our findings support that a comprehensive method that combines MRI structural and metabolic data of brain regions can improve model classification efficiency of AD.

Assistive tools for classifying neurological disorders using fMRI and deep learning: A guide and example

“…For example, Wang et al. (2023) classified AD from controls using ROI methods. Specifically, they identified ROIs using the AAL atlas and then created connectivity matrices using a phase synchronization index approach.…”

An Efficient 3D CNN Framework with Attention Mechanisms for Alzheimer’s Disease Classification

“…To tackle the problem of over-fitting and poor performance due to the limited image samples, deep metric learning is employed in a deep triplet network with a conditional loss function, improving the accuracy of the model. A novel approach has been proposed to enhance the accuracy of diagnosing and classifying AD using a combination of MRI brain structural data and metabolite levels from the frontal and parietal regions [22]. The method utilizes a stacked auto-encoder neural network to classify individuals as either AD or healthy controls.…”

Multichannel electrochemical workstation-based data collection combined with machine learning for online analysis of tyrosine

“…Moreover, machine learning (ML) establishes a link between the input and target output values for an array of multiple data eigenvalues by building a specific function. Therefore, it has been applied to the fields of materials engineering, 23 mathematical operations, arts, humanities, 24 life sciences, biomedicine, 25,26 and physics. 27 Artificial neural network (ANN), a branch of ML, is widely used owing to its advantages, such as small code size, fast learning rate, and small data requirements.…”